<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C1321489" disease_type="Neoplastic Process" abbrv="">Muir-Torre syndrome</z:e> (MTS), a phenotypic variant of the more common <z:e sem="disease" ids="C1333990" disease_type="Neoplastic Process" abbrv="">hereditary nonpolyposis colorectal cancer</z:e> syndrome, or <z:e sem="disease" ids="C0009405" disease_type="Neoplastic Process" abbrv="">Lynch syndrome</z:e>, is an autosomal dominantly inherited condition that combines at least one cutaneous sebaceous <z:hpo ids='HP_0002664'>neoplasm</z:hpo> and at least one visceral <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Most patients (~90%) with MTS carry mutations in the MSH2 gene; less than 10% of the cases are associated with a mutation MLH1 gene, and only 3 MTS patients with a pathogenic MSH6 mutation have been previously documented </plain></SENT>
<SENT sid="2" pm="."><plain>We report a family affected with MTS in which 3 members (father and 2 sons) were found to harbor a missense mutation c.2633T&gt;C (p.V878A) in exon 4 of the MSH6 gene </plain></SENT>
</text></document>